AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Dec 18, 2014
30071_dirs_2014-12-18_7efd2176-d24c-4804-9166-8a73f1456edd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-12-17
Reporting Person: FARRELL PETER C (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-16 | ResMed Common Stock | G | 64966 | — | Disposed | 193851 | Direct |
| 2014-12-17 | ResMed Common Stock | G | 25987 | — | Disposed | 167864 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 22783 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Represents a gift to the Farrell Family Foundation, a 501(c)(3) non-profit corporation. Dr. Farrell is a co-trustee, but has no beneficial interest, control or dispositive power over the gifted shares.
F2: Represents a gift to the Peter C. Farrell Charitable Remainder Unitrust. Dr. Farrell is not a trustee and has no beneficial interest, control or dispositive power over the gifted shares.
F3: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29